
Join to View Full Profile
1585 Third StFort Polk, LA 71459
Phone+1 337-531-3705
Dr. Conduah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daisy Conduah is an Obstetrics & Gynecology specialist located in Fort Polk, LA. She completed her medical education at the Wright State University Boonshoft School of Medicine, followed by an internship in Surgery at the National Capital Consortium and a residency in Obstetrics and Gynecology at Tripler Army Medical Center. Dr. Conduah currently serves as the Chief at Bayne-Jones Army Community Hospital since 2023, having previously worked at Carl R. Darnall Army Medical Center and Hawks Troop Medical Clinic. Her research contributions include publications on immunology and inflammatory bowel diseases, with several works cited multiple times in other scholarly articles.
Education & Training
- Tripler Army Medical CenterResidency, Obstetrics and Gynecology, 2016 - 2020
- National Capital ConsortiumInternship, Surgery, 2013 - 2014
- Wright State University Boonshoft School of MedicineClass of 2013
Certifications & Licensure
- GA State Medical License 2014 - 2026
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- 35 citationsThe role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasiaYasmín Hernández, John P. Sotolongo, Keith J. Breglio, Daisy E. Conduah, Anli Chen
BMC Gastroenterology. 2010-07-16 - 121 citationsInnate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.Masayuki Fukata, Yasmín Hernández, Daisy E. Conduah, Jason P. Cohen, Anli Chen
Inflammatory Bowel Diseases. 2009-07-01 - 97 citationsThe Myeloid Differentiation Factor 88 (MyD88) Is Required for CD4+ T Cell Effector Function in a Murine Model of Inflammatory Bowel DiseaseMasayuki Fukata, Keith J. Breglio, Anli Chen, Arunan S. Vamadevan, Tyralee Goo
Journal of Immunology. 2008-02-01
Professional Memberships
- Fellow
- National Medical AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: